Physical Medicine & Rehabilitation · Lincoln, NE
NPI
1306955661
Since 2006
Specialty
Physical Medicine & Rehabilitation
Code 208100000X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
5401 South Street
Lincoln, NE, 68506
Phone (402) 413-3531
Groups this clinician bills Medicare through
Medicare paid, 2024
$32K
541 services
Medicare patients, 2024
74
Average age 67
Drug cost, 2024
$102K
717 prescriptions
Company payments, 2025
$511
From 7 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Paul L Krabbenhoft was code 99232 (hospital e&m - subsequent), 378 times for 35 patients. In total Paul L Krabbenhoft billed 541 services in 11 codes, and Medicare paid $32K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2013-07-02.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99232 Hospital E&M - Subsequent | Facility | 378 | 35 | $56.34 | $21K |
| 99214 Office E&M - Established | Facility | 49 | 28 | $63.08 | $3,091 |
| 99231 Hospital E&M - Subsequent | Facility | 32 | 15 | $35.76 | $1,144 |
| 99223 Hospital E&M - Initial | Facility | 23 | 21 | $125.98 | $2,898 |
| 99238 Hospital Discharge Management | Facility | 21 | 21 | $58.88 | $1,237 |
By year: 2022 $53K for 991 services; 2023 $34K for 603 services; 2024 $32K for 541 services.
Medicare prescription drug claims, 2024
In 2024, the drug Paul L Krabbenhoft prescribed most often to Medicare patients was Baclofen, with 101 prescriptions and refills. In total Paul L Krabbenhoft wrote 717 Medicare prescriptions that cost $102K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Baclofen Generic | 101 | 194 | 23 | $6,929 |
| Gabapentin Generic | 61 | 95 | 21 | $2,838 |
| Dantrolene Sodium Generic | 53 | 76 | 11 | $9,208 |
| Myrbetriq Mirabegron | 49 | 70 | Under 11 | $32K |
| Diazepam Generic | 22 | 22 | Under 11 | $211 |
| Pregabalin Generic | 22 | 34 | Under 11 | $1,027 |
| Tizanidine Hcl Generic | 22 | 46 | Under 11 | $659 |
| Celecoxib Generic | 20 | 38 | Under 11 | $388 |
| Methenamine Hippurate Generic | 19 | 29 | Under 11 | $1,509 |
| Trazodone Hcl Generic | 19 | 19 | 12 | $77.46 |
| Oxybutynin Chloride Generic | 17 | 47 | Under 11 | $681 |
| Gemtesa Vibegron | 16 | 33 | Under 11 | $15K |
| Oxybutynin Chloride Er Oxybutynin Chloride | 15 | 19 | Under 11 | $214 |
| Solifenacin Succinate Generic | 15 | 27 | Under 11 | $311 |
| Amitriptyline Hcl Generic | 14 | 14 | Under 11 | $116 |
Brand drugs: 121 claims; generic drugs: 596 claims; opioid claims: 12.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Paul L Krabbenhoft $511 ($511 in general payments such as food, travel and fees) from 7 companies. The largest payer was Abbvie Inc. with $123.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.